Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications
Nathaniel J. Henning, Andrew G. Manford, Jessica N. Spradlin, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 2, pp. 701-708
Open Access | Times Cited: 158

Showing 26-50 of 158 citing articles:

Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond
Yue Zhong, Fanglian Chi, Hanyu Wu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114142-114142
Closed Access | Times Cited: 41
Targeted protein degradation in cancers: Orthodox PROTACs and beyond
Jin Li, Xinxin Chen, Aiping Lü, et al.
The Innovation (2023) Vol. 4, Iss. 3, pp. 100413-100413
Open Access | Times Cited: 36
Targeted Protein Degradation through E2 Recruitment
Nafsika Forte, Dustin Dovala, Matthew J. Hesse, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 4, pp. 897-904
Open Access | Times Cited: 36
E3-Specific Degrader Discovery by Dynamic Tracing of Substrate Receptor Abundance
Alexander Hanzl, Eleonora Barone, Sophie Bauer, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 2, pp. 1176-1184
Open Access | Times Cited: 31
The rise of degrader drugs
Mingxing Teng, Nathanael S. Gray
Cell chemical biology (2023) Vol. 30, Iss. 8, pp. 864-878
Open Access | Times Cited: 28
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design
Dazhao Mi, Yuzhan Li, Haijun Gu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115444-115444
Closed Access | Times Cited: 27
E3 ligase ligand optimization of Clinical PROTACs
Hanrui Jiang, Huan Xiong, Shuang-Xi Gu, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 26
E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology
Iacovos N. Michaelides, Gavin W. Collie
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3173-3194
Open Access | Times Cited: 26
Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency
Charu Chaudhry
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6239-6250
Closed Access | Times Cited: 26
Glucose-responsive, antioxidative HA-PBA-FA/EN106 hydrogel enhanced diabetic wound healing through modulation of FEM1b-FNIP1 axis and promoting angiogenesis
Wenqian Zhang, Kangkang Zha, Yuan Xiong, et al.
Bioactive Materials (2023) Vol. 30, pp. 29-45
Open Access | Times Cited: 26
Reversible Dual-Covalent Molecular Locking of the 14-3-3/ERRγ Protein–Protein Interaction as a Molecular Glue Drug Discovery Approach
B. Somsen, Rick J.C. Schellekens, Carlo J. A. Verhoef, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 12, pp. 6741-6752
Open Access | Times Cited: 25
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies
Xiaopeng Peng, Zhihao Hu, Limei Zeng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 533-578
Open Access | Times Cited: 25
Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation
Seong Ho Hong, Anand Divakaran, Akane Osa, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 2, pp. 442-450
Open Access | Times Cited: 14
Structure-Guided Design and Optimization of Covalent VHL-Targeted Sulfonyl Fluoride PROTACs
Rishi R. Shah, Elena De Vita, Preethi S. Sathyamurthi, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4641-4654
Open Access | Times Cited: 12
Degraders in epigenetic therapy: PROTACs and beyond
Xing‐Jie Dai, Shi‐Kun Ji, Meng‐Jie Fu, et al.
Theranostics (2024) Vol. 14, Iss. 4, pp. 1464-1499
Open Access | Times Cited: 11
Increasing the Throughput and Reproducibility of Activity-Based Proteome Profiling Studies with Hyperplexing and Intelligent Data Acquisition
Hanna G. Budayeva, P. Taylur, Shuai Wang, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 8, pp. 2934-2947
Open Access | Times Cited: 9
Expanding the ligand spaces for E3 ligases for the design of protein degraders
Rahman Shah Zaib Saleem, Martin P. Schwalm, Stefan Knapp
Bioorganic & Medicinal Chemistry (2024) Vol. 105, pp. 117718-117718
Open Access | Times Cited: 9
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access | Times Cited: 1
Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders
Felix Feller, Irina Honin, Martina Miranda, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein Degradation
Jianyu Yan, Tengfei Li, Zhenyuan Miao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 8798-8827
Closed Access | Times Cited: 30
Applications of covalent chemistry in targeted protein degradation
Dong Lu, Xin Yu, Hanfeng Lin, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 22, pp. 9243-9261
Open Access | Times Cited: 29
Sulfamate Acetamides as Self-Immolative Electrophiles for Covalent Ligand-Directed Release Chemistry
Rambabu Reddi, Adi Rogel, Ronen Gabizon, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 6, pp. 3346-3360
Open Access | Times Cited: 22
Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence
Miquel Duran‐Frigola, Marko Cigler, Georg E. Winter
Journal of the American Chemical Society (2023) Vol. 145, Iss. 5, pp. 2711-2732
Open Access | Times Cited: 21
New Insights into Oxidative and Reductive Stress Responses and Their Relation to the Anticancer Activity of Selenium-Containing Compounds as Hydrogen Selenide Donors
Agnieszka Krakowiak, Sylwia Pietrasik
Biology (2023) Vol. 12, Iss. 6, pp. 875-875
Open Access | Times Cited: 21

Scroll to top